CAMBRIDGE, Mass., Jan. 8 /PRNewswire/ -- Variagenics, Inc. (Nasdaq: VGNX),
a leader in pharmacogenomics, today announced that its presentation at the JP
Morgan H&Q Healthcare Conference is scheduled for Wednesday, January 9, 2002
at 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time). This event will be webcast
live and may be accessed at http://www.variagenics.com. The replay will be available
for two weeks after the event.
Taylor J. Crouch Variagenics' President & CEO, will speak. The
presentation will take place at the Westin St. Francis Hotel in San Francisco,
CA.
Variagenics, Inc. applies its pharmacogenomic technologies to the
discovery, development and commercialization of personalized drugs and
companion molecular diagnostic products. Using a drug pathway approach, the
Company identifies therapeutically important genetic markers, including SNPs,
haplotypes and LOH indicators. This information is then applied to clinical
programs to enhance drugs in development, and ultimately to the creation of
diagnostics for predicting patient response to drugs.
For more information visit the Company's website at http://www.variagenics.com.
Contact:
Paul Kidwell
Media Relations
617/588-5340
pkidwell@variagenics.com
SOURCE Variagenics, Inc.
 back to top
Related links:
http://www.variagenics.com
CONTACT:
Paul Kidwell, Media Relations of Variagenics,
+1-617-588-5340, pkidwell@variagenics.com
|
